J0893 HCPCS Level II code: Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
J0893 is the HCPCS code for “Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
Short description: Inj, decitabine (sun pharma)
HCPCS · United States
Medicare details
The indicators CMS publishes with J0893 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2023
Where J0893 sits
- 1J codesDrugs administered other than orally
- 2Active code J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0893 mean?
J0893 is the HCPCS code for “Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0893?
CMS lists J0893’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0893
All J codesJ0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)J0888Injection, epoetin beta, 1 microgram, (for non esrd use)J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)J0894Injection, decitabine, 1 mgJ0895Injection, deferoxamine mesylate, 500 mgJ0896Injection, luspatercept-aamt, 0.25 mgJ0897Injection, denosumab, 1 mgJ0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)